by Fadi Agour, J.D. | Jan 19, 2026 | All Posts
A Major Shift in the Depo-Provera Landscape If you’ve been watching the Depo-Provera litigation from the sidelines, it’s time to get in the game. For decades, the birth control shot was marketed as a convenient alternative to the pill, but as of December 2025, the...
by Fadi Agour, J.D. | Jan 14, 2026 | All Posts
Find out what’s happening with Talc cases and how firms can still profit from ongoing leads. The landscape of the Talcum Powder litigation—specifically the claims against Johnson & Johnson—has been completely reshaped. After years of legal maneuvering designed to...
by Fadi Agour, J.D. | Jan 9, 2026 | All Posts
Optimizing Mass Tort Intake to Maximize ROI Law firms invest millions into mass tort lead generation, using sophisticated ads across TV, social media, and search. Yet, the high volume of leads rarely translates directly into an equally high volume of signed retainers....
by Fadi Agour, J.D. | Jan 4, 2026 | All Posts, Blogs
The State of the Docket: Is There Still Opportunity? After years of massive, high-profile settlements—with Bayer allocating billions of dollars to resolve roughly 100,000 claims—many law firms assume the Roundup litigation is finally winding down. Here’s the reality:...
by Fadi Agour, J.D. | Dec 28, 2025 | All Posts, Blogs
The New Mass Tort Challenge: Sensitivity Meets Scale The Hair Relaxer litigation—centered on allegations that chemicals like endocrine-disrupting chemicals (EDCs) found in common products are linked to serious hormone-sensitive cancers—is one of the fastest-growing...
